Rapamycin synergizes cisplatin sensitivity in basal-like breast cancer cells through up-regulation of p73 Su Wei WongKai Hung TiongChee-Onn Leong Preclinical study 05 August 2010 Pages: 301 - 313
RERG (Ras-like, oestrogen-regulated, growth-inhibitor) expression in breast cancer: a marker of ER-positive luminal-like subtype Hany Onsy HabashyDesmond G. PoweIan O. Ellis Preclinical study 10 August 2010 Pages: 315 - 326
Accumulation of mutations over the entire mitochondrial genome of breast cancer cells obtained by tissue microdissection Liane FendtHarald NiederstätterWalther Parson Preclinical study 10 August 2010 Pages: 327 - 336
CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo Manuel KochFadi HusseinThomas Hawighorst Preclinical study Open access 17 August 2010 Pages: 337 - 346
Trastuzumab-DM1 (T-DM1) retains all the mechanisms of action of trastuzumab and efficiently inhibits growth of lapatinib insensitive breast cancer Teemu T. JunttilaGuangmin LiMark X. Sliwkowski Preclinical study 21 August 2010 Pages: 347 - 356
Transient over-expression of estrogen receptor-α in breast cancer cells promotes cell survival and estrogen-independent growth Robert S. TolhurstRoss S. ThomasLaki Buluwela Preclinical study 22 August 2010 Pages: 357 - 368
The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy Gabriel FaranteStefano ZurridaUmberto Veronesi Preclinical study 26 August 2010 Pages: 369 - 378
Erratum to: The management of ductal intraepithelial neoplasia (DIN): open controversies and guidelines of the Istituto Europeo di Oncologia (IEO), Milan, Italy Gabriel FaranteStefano ZurridaUmberto Veronesi Erratum 21 September 2010 Pages: 379 - 379
Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts Mamoru NukatsukaHitoshi SaitoMamoru Kiniwa Preclinical study 31 August 2010 Pages: 381 - 390
Distinct function of androgen receptor coactivator ARA70α and ARA70β in mammary gland development, and in breast cancer Xinyu WuFei ChenPeng Lee Preclinical study 03 September 2010 Pages: 391 - 400
Topoisomerase II alpha protein and responsiveness of breast cancer to adjuvant chemotherapy with CEF compared to CMF in the NCIC CTG randomized MA.5 adjuvant trial F. P. O’MalleyS. ChiaK. I. Pritchard Clinical Trial 26 April 2011 Pages: 401 - 409
Effects of music therapy on pain among female breast cancer patients after radical mastectomy: results from a randomized controlled trial Xiao-Mei LiHong YanYin-Ping Zhang Clinical trial 03 May 2011 Pages: 411 - 419
Prospective randomized trial of 5-fluorouracil, doxorubicin, and cyclophosphamide (FAC) versus paclitaxel and FAC (TFAC) in patients with operable breast cancer: impact of taxane chemotherapy on locoregional control Jeffrey M. AlbertAman U. BuzdarJulia L. Oh Clinical trial 08 May 2011 Pages: 421 - 427
Lobular and non-lobular breast cancers differ regarding axillary lymph node metastasis: a cross-sectional study on 4,292 consecutive patients T. VandorpeA. SmeetsP. Neven Clinical trial 12 May 2011 Pages: 429 - 435
Epirubicin and paclitaxel with G-CSF support in first line metastatic breast cancer: a randomized phase II study of dose-dense and dose-escalated chemotherapy R. I. LalisangF. L. G. ErdkampH. C. Schouten Clinical trial 17 May 2011 Pages: 437 - 445
Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer E. RazisM. BobosG. Fountzilas Clinical trial 19 May 2011 Pages: 447 - 456
G-protein-coupled estrogen receptor GPR30 and tamoxifen resistance in breast cancer Atanas IgnatovTanja IgnatovThomas Kalinski Clinical Trial 24 May 2011 Pages: 457 - 466
Current evidence on the relationship between HRAS1 polymorphism and breast cancer risk: a meta-analysis Chun ZhangGuo-Qiang LvPing Zhou Epidemiology 09 January 2011 Pages: 467 - 472
Significant changes in dietary intake and supplement use after breast cancer diagnosis in a UK multicentre study Louiza S. VelentzisMohammed R. KeshtgarMarie M. Cantwell Epidemiology 11 January 2011 Pages: 473 - 482
Breast cancer as heterogeneous disease: contributing factors and carcinogenesis mechanisms Julia KravchenkoIgor AkushevichH. Kim Lyerly Epidemiology 12 January 2011 Pages: 483 - 493
Improved survival of patients with primary distant metastatic breast cancer in the period of 1995–2008. A nationwide population-based study in the Netherlands J. RuiterkampM. F. ErnstA. C. Voogd Epidemiology 15 January 2011 Pages: 495 - 503
Image-guided sampling reveals increased stroma and lower glandular complexity in mammographically dense breast tissue Suling J. LinJennifer CawsonErik W. Thompson Epidemiology 22 January 2011 Pages: 505 - 516
Socioeconomic inequalities in attending the mass screening for breast cancer in the south of the Netherlands—associations with stage at diagnosis and survival M. J. AartsA. C. VoogdW. J. Louwman Epidemiology 03 February 2011 Pages: 517 - 525
Functional polymorphisms in CD166/ALCAM gene associated with increased risk for breast cancer in a Chinese population Ping ZhouLiang-Feng DuChun Zhang Epidemiology 04 February 2011 Pages: 527 - 534
Breast cancer screening and ethnicity in the United States: implications for health disparities research Patricia Y. MirandaWassim TarrafHector M. González Epidemiology 06 February 2011 Pages: 535 - 542
Breast cancers in U.S. residing Indian-Pakistani versus non-Hispanic White women: comparative analysis of clinical-pathologic features, treatment, and survival Meena S. MoranLou GonsalvesShuangge Ma Epidemiology 08 February 2011 Pages: 543 - 551
Is the toxicity of adjuvant aromatase inhibitor therapy underestimated? Complementary information from patient-reported outcomes (PROs) Anne OberguggenbergerMichael HubalekBernhard Holzner Epidemiology 11 February 2011 Pages: 553 - 561
Breast cancer scalp metastasis as first metastatic site after scalp cooling: Two cases of occurrence after 7- and 9-year follow-up Julie LemieuxChristine DesbiensJean-Charles Hogue Brief Report 24 March 2011 Pages: 563 - 566
Reproductive factors associated with mammographic density: a Korean co-twin control study Joohon SungYun-Mi SongDonghun Lee Brief Report 26 March 2011 Pages: 567 - 572
Germline ATM mutational analysis in BRCA1/BRCA2 negative hereditary breast cancer families by MALDI-TOF mass spectrometry B. GrañaL. FachalJ. Brunet Brief Report 29 March 2011 Pages: 573 - 579
The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer Steven A. Narod Brief Report 01 April 2011 Pages: 581 - 583
Limited evidence supported the association of HRAS1 polymorphism with breast cancer risk Xiujun ZhangMengchun Jia Letter to the Editor 20 February 2011 Pages: 585 - 587
No evidence indicated that polymorphisms of the matrix metalloproteinases genes were associated with breast cancer risk: an update Taiping He Letter to the Editor 20 February 2011 Pages: 589 - 591
Tumor necrosis factor-α 308 G/A polymorphism in breast cancer risk Zhishan DingFusheng JiangGuiyuan Lv Letter to the Editor 25 February 2011 Pages: 593 - 594
Endothelial nitric oxide synthase (eNOS) G894T polymorphism is not associated with breast cancer risk: new evidence Huazhou FuYangqing ZhangZhishan Ding Letter to the Editor 16 March 2011 Pages: 595 - 598
